In SCID mice with human medulloblastoma xenografts, HNG did not affect the significant anti-tumor action of TMZ.
In plain wordsIn mice with human tumor grafts, HNG did not reduce the tumor-fighting effect of TMZ.
- Peptide
- Humanin
- Outcome
- No significant changeTMZ anti-tumor action with HNG
- Study
mousen: not reported in source
Male SCID mice bearing human medulloblastoma DAOY xenografts- Comparator
- TMZ alone
- Outcome group
- Tumor growth · Cancer
- Studied dose
- Dose not stated
Source sentences
HNG did not affect TMZ's significant anti-tumor action.
2 context sentences(design, population, supporting numbers)
In this study, we utilized severe combined immuno-deficiency (SCID) mice bearing human medulloblastoma to study the effect of HNG in Temozolomide (TMZ) induced male germ cell apoptosis and white blood cell (WBC) suppression.
Three weeks later, groups of tumor-bearing mice received one of the following treatments: vehicle, HNG, TMZ, or TMZ + HNG.